Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,984,261
Closed -$17.9M 3983
2026
Q1
$17.9M Buy
2,984,261
+2,025,571
+211% +$13.4M 0.02% 864
2025
Q4
$5.59M Buy
+958,690
New +$5.34M 0.01% 1765
2025
Q1
Sell
-1,333,810
Closed -$6.76M 2025
2024
Q4
$6.76M Buy
+1,333,810
New +$7.37M 0.01% 851
2022
Q4
Sell
-1,852,081
Closed -$2.2M 1501
2022
Q3
$2.2M Sell
1,852,081
-3,147,919
-63% -$3M 0.01% 911
2022
Q2
$2.95M Buy
+5,000,000
New +$3.68M 0.01% 845
2021
Q4
Sell
-600,000
Closed -$792K 1081
2021
Q3
$792K Buy
+600,000
New +$1.6M ﹤0.01% 885
2020
Q4
Sell
-73,091
Closed -$384K 896
2020
Q3
$384K Buy
+73,091
New +$439K ﹤0.01% 838

Other funds holding ARDX

Steven Cohen's ARDX Position: Q2 2026 in Review

Steven Cohen sold out of Ardelyx (ARDX) in Q2 2026, closing a stake of 2,984,261 shares — an estimated $17.9M sold.

Steven Cohen first reported a position in ARDX in Q3 2020 and held it in 7 quarters. The position peaked at $17.9M in Q1 2026. 248 funds tracked by Wall St. Rank hold ARDX as of Q2 2026.

  • Steven Cohen reported no remaining Ardelyx position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 2,984,261 Ardelyx shares in Q2 2026, an estimated $17.9M.
  • Steven Cohen first reported a position in Ardelyx in Q3 2020 and held it in 7 quarters.
  • Steven Cohen's Ardelyx position peaked at $17.9M in Q1 2026.
  • 248 funds tracked by Wall St. Rank held Ardelyx as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.